藥物新聞報導與藥物廣告法律責任【醫事法學教室】 試閱
The Freedom of Pharmaceutical Press and Legal Responsibilities of Pharmaceutical advertisements
甲媒體對乙廠商一項新的醫療器材發展作了專題報導,卻被衛生主管機關認為構成藥物廣告,而以非藥商不得為藥物廣告為由課處罰鍰。本案爭點在於藥物新聞和藥物廣告應如何區分,才能平衡新聞自由與藥物廣告管制間之衝突。建議主管機關應訂定明確之藥物廣告認定標準,尤其是藥物廣告主觀上招徠銷售目的之要件,以免過度限制人民之言論自由。
Press A did an in-depth coverage about new medical equipment which belongs to the corporation B, but was sentenced to fine by the Health Administration. The reason is that only the pharmacist is authorized to advertise medicine, and the Health Administration claimed that the in-depth coverage made by press A was an advertisement. The issue of law in this case is how to difference the news report and the advertisement about medicine, therefore we could moderate the conflict between the freedom of the press and the medicine information control. The author advises that authorities should formulate clearly criteria to determine what an advertisement of medicine is, especially for the canvass as an elements of subjective purpose in medicine advertising to avoid restricting the freedom of the speech for people unduly.
185-190